Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000380121 | SCV000432142 | uncertain significance | Mitochondrial DNA depletion syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000285798 | SCV000432143 | uncertain significance | Mitochondrial DNA depletion syndrome 9 | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000603149 | SCV000715039 | likely benign | not specified | 2017-01-26 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000285798 | SCV002466222 | likely benign | Mitochondrial DNA depletion syndrome 9 | 2023-12-07 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003950167 | SCV004760964 | likely benign | SUCLG1-related disorder | 2019-12-04 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |